Iconovo (Sweden) Performance
| ICO Stock | SEK 1.14 0.04 3.64% |
The company retains a Market Volatility (i.e., Beta) of 0.69, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Iconovo's returns are expected to increase less than the market. However, during the bear market, the loss of holding Iconovo is expected to be smaller as well. At this point, Iconovo has a negative expected return of -1.02%. Please make sure to check out Iconovo's value at risk, rate of daily change, relative strength index, as well as the relationship between the kurtosis and market facilitation index , to decide if Iconovo performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Iconovo has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 61.7 M | |
| Total Cashflows From Investing Activities | -26 M |
Iconovo |
Iconovo Relative Risk vs. Return Landscape
If you would invest 218.00 in Iconovo on October 3, 2025 and sell it today you would lose (104.00) from holding Iconovo or give up 47.71% of portfolio value over 90 days. Iconovo is producing return of less than zero assuming 2.8786% volatility of returns over the 90 days investment horizon. Simply put, 25% of all stocks have less volatile historical return distribution than Iconovo, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Iconovo Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Iconovo's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Iconovo, and traders can use it to determine the average amount a Iconovo's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.3528
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ICO |
Estimated Market Risk
| 2.88 actual daily | 25 75% of assets are more volatile |
Expected Return
| -1.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.35 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Iconovo is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Iconovo by adding Iconovo to a well-diversified portfolio.
Iconovo Fundamentals Growth
Iconovo Stock prices reflect investors' perceptions of the future prospects and financial health of Iconovo, and Iconovo fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Iconovo Stock performance.
| Return On Equity | -0.32 | |||
| Return On Asset | -0.17 | |||
| Profit Margin | (1.18) % | |||
| Operating Margin | (1.20) % | |||
| Current Valuation | 417.92 M | |||
| Shares Outstanding | 8.85 M | |||
| Price To Book | 4.25 X | |||
| Price To Sales | 13.36 X | |||
| Revenue | 15.41 M | |||
| EBITDA | (20.45 M) | |||
| Cash And Equivalents | 94.94 M | |||
| Cash Per Share | 6.84 X | |||
| Book Value Per Share | 11.96 X | |||
| Cash Flow From Operations | (11.01 M) | |||
| Earnings Per Share | (3.31) X | |||
| Total Asset | 148.54 M | |||
About Iconovo Performance
Assessing Iconovo's fundamental ratios provides investors with valuable insights into Iconovo's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Iconovo is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Iconovo AB develops and licenses inhalation devices in Sweden. Iconovo AB was founded in 2013 and is based in Lund, Sweden. Iconovo AB operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. It employs 27 people.Things to note about Iconovo performance evaluation
Checking the ongoing alerts about Iconovo for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Iconovo help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Iconovo generated a negative expected return over the last 90 days | |
| Iconovo may become a speculative penny stock | |
| Iconovo has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 15.41 M. Net Loss for the year was (26.16 M) with profit before overhead, payroll, taxes, and interest of 21.31 M. | |
| Iconovo has accumulated about 94.94 M in cash with (11.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.84, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 48.0% of the company shares are held by company insiders |
- Analyzing Iconovo's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Iconovo's stock is overvalued or undervalued compared to its peers.
- Examining Iconovo's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Iconovo's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Iconovo's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Iconovo's stock. These opinions can provide insight into Iconovo's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Iconovo Stock Analysis
When running Iconovo's price analysis, check to measure Iconovo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iconovo is operating at the current time. Most of Iconovo's value examination focuses on studying past and present price action to predict the probability of Iconovo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iconovo's price. Additionally, you may evaluate how the addition of Iconovo to your portfolios can decrease your overall portfolio volatility.